FindTrial
Sign In

THE EFFICACY AND SAFTEY OF AN INJECTION NAMED NEFOPAM HYDROCHLORIDE FOR PAIN RELIEF AFTER UNDERGOING LOWERLIMB SURGERIES UNDER SPINAL ANAESTHESIA.

THE EFFICACY AND SAFETY OF INTRAVENOUS NEFOPAM HYDROCHLORIDE AS POSTOPERATIVE ANALGESIC IN GERIATRIC PATIENTS UNDERGOING LOWER LIMB ORTHOPAEDIC SURGERIES UNDER SPINAL ANAESTHESIA.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/037887
Enrollment
96
Registered
2021-11-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: V00-Y99- External causes of morbidity

Interventions

Intervention1: Nefopam hydrochloride: NefopAm hydrochloride will be given as postoperative analgesia. Intervention2: Nefopam hydrochloride: Nefopam hydrochloride will be given as postoperative analges

Sponsors

JSS MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Asa 1/2 Undergoing lower limb orthopaedic surgeries under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: Patients undergoing emergency surgeries, patients with renal and hepatic insufficiency , patients with convulsive disorders and on MAO-inhibitor drugs , patients having itâ??d and those with cognitive dysfunction.

Design outcomes

Primary

MeasureTime frame
To evaluate degree of pain relief and to determine duration of analgesia of Nefopam hydrochloride.Timepoint: Postoperatively when NRS score is 4 and 4th hourly till 24 hours.—

Secondary

MeasureTime frame
To assess the rescue analgesic requirement , variations in hemodynamic parameters and to study adverse effects of nefopam in elderly people.Timepoint: Postoperatively when NRS score is 4 and 4th hourly till 24 hours.—

Countries

India

Contacts

Public ContactDr Nalini Kotekar

JSSH Mysore

nalinikotekar@gmail.com9845112283

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026